-
'Superbug' Infections Down 30 Percent at VA Hospitals
drugs.com
January 09, 2017
Rates of a deadly "superbug" called methicillin-resistant Staphylococcus aureus, or MRSA, have dropped steadily at hospitals and long-term care health care facilities run by the U.S. Department of Veterans Affairs over the past eight years, according to a
-
Flu Season Starting to Peak
drugs.com
January 09, 2017
Flu season is in full swing and it's starting to look like a severe one, U.S. health officials said Friday.
-
Technology and strategies of the immunodiagnostics market.
pharmaasia
January 09, 2017
The global immunodiagnostics market is nearing its matured stage, and is thriving in the developed regions of the world.
-
Fortress Biotech Forms New Subsidiary
contractpharma
January 09, 2017
Caelum Biosciences together with Columbia Univ. to develop novel treatment for AL amyloidosis
-
New research shows how cancer cells break free of physical restraints to grow and spread
pharmaceutical-technology
January 09, 2017
New research carried out by scientists at The Institute of Cancer Research (ICR) in London has shown how cancer cells can break free of the physical restraints imposed by their surroundings to grow and spread around the body.
-
M&As this week: Northern Biologics, Sumitomo Dainippon Pharma, Premaitha Health
pharmaceutical-technology
January 09, 2017
Canadian-based biotechnology company Northern Biologics has merged with Mosaic Biomedicals, a biotechnology company located in Spain.
-
Deals this week: Sucampo Pharmaceuticals, Satsuma Pharmaceuticals, Nanjing Hicin Pharmaceutical
pharmaceutical-technology
January 09, 2017
Chinese pharmaceutical company, Nanjing Hicin Pharmaceutical has announced an initial public offering (IPO) of shares to raise ¥22.22bn ($3.19bn) in gross proceeds.
-
HUB and Dutch Health Insurance Companies to Validate Use of Organoids for Cystic Fibrosis
b3cnewswire
January 09, 2017
Hubrecht Organoid Technology (HUB), and the health insurance companies CZ, Zilveren Kruis, and Menzis announced today that they will start a €3 million validation trial for use of HUB Organoid Technology...
-
RedHill Biopharma Announces YELIVA® (ABC294640) Abstract Presentation at the 2017 Cholangiocarcinoma
b3cnewswire
January 09, 2017
The abstract, to be presented at the upcoming 2017 Cholangiocarcinoma Foundation Annual Conference, describes positive findings from non-clinical studies...
-
110 students graduate from Biocon Academy
financialexpress
January 09, 2017
The convocation ceremony was held recently in Bengaluru.